Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;100(2):230-244.
doi: 10.1111/cbdd.14060. Epub 2022 Jun 6.

Synthesis, molecular docking, and biological evaluation of novel 1,2,4-triazole-isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors

Affiliations

Synthesis, molecular docking, and biological evaluation of novel 1,2,4-triazole-isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors

Vedika G Dadlani et al. Chem Biol Drug Des. 2022 Aug.

Abstract

The issue of emerging resistance to antitubercular drugs has created a formidable barrier in the effective prevention and cure of tuberculosis globally. In an effort to search for new antimycobacterial agents, possibly comprising new pharmacophore, novel triazole-isatin derivatives were designed as Mycobacterium tuberculosis shikimate kinase inhibitors and synthesized by microwave-assisted method. The synthesized molecules were evaluated for their antimycobacterial activity by MABA assay against M. tuberculosis H37Rv. The molecule 5h demonstrated MIC of 0.8 μg/ml and good safety profile with higher selectivity index with HEK293 cell line. The antimycobacterial activity was further substantiated with molecular docking studies. The triazole-isatin derivatives showed significant binding interactions with amino acid residues in the active site of the enzyme. These studies revealed that molecule 5h could act as a potential lead molecule for further studies to find new target-directed molecules.

Keywords: HEK293 cell line; MABA assay; docking; druglikeness; shikimate kinase inhibitor; triazole-isatin.

PubMed Disclaimer

References

REFERENCES

    1. Arcuri, H. A., Zafalon, G. F. D., Marucci, E. A., Bonalumi, C. E., da Silveira, N. J. F., Machado, J. M., de Azevedo, W. F., & Palma, M. S. (2010). SKPDB: A structural database of shikimate pathway enzymes. BMC Bioinformatics, 11(1), 12. https://doi.org/10.1186/1471-2105-11-12
    1. Bentley, R., & Haslam, E. (1990). The shikimate pathway-A metabolic tree with many branche. Critical Reviews in Biochemistry and Molecular Biology, 25(5), 307-384. https://doi.org/10.3109/10409239009090615
    1. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235-242. https://doi.org/10.1093/nar/28.1.235
    1. Bhat, S. S., Revankar, V. K., Kumbar, V., Bhat, K., & Kawade, V. A. (2018). Synthesis, crystal structure and biological properties of a cis-dichloridobis (diimine) copper (II) complex. Acta Crystallographica Section C: Structural Chemistry, 74(2), 146-151. https://doi.org/10.1107/S2053229617018551
    1. Blanco, B., Prado, V., Lence, E., Otero, J. M., Garcia-Doval, C., van Raaij, M. J., Llamas-Saiz, A. L., Lamb, H., Hawkins, A. R., & González-Bello, C. (2013). Mycobacterium tuberculosis shikimate kinase inhibitors: Design and simulation studies of the catalytic turnover. Journal of the American Chemical Society, 135(33), 12366-12376. https://doi.org/10.1021/ja405853p

MeSH terms

LinkOut - more resources